The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
Article in Frontiers in Endocrinology (October 2023)
The most recent citing publications are shown below. View all 100 publications that cite this research output on Dimensions.
Anti–MUC1 nanobody can synergize the Tamoxifen and Herceptin effects on breast cancer cells by inducing ER, PR and HER2 overexpression
Article in International Immunopharmacology (August 2023)
Molecular Pathways in Breast Cancer Chemoresistance
Book chapter (July 2023)